Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.
复制标题
DOI:
10.1021/jm301448p
复制
发表时间:
2013-01-10
影响因子:
7.3
通讯作者:
Fesik, Stephen W.
中科院分区:
文献类型:
--
作者:
Friberg, Anders;Vigil, Dominico;Zhao, Bin;Daniels, R. Nathan;Burke, Jason P.;Garcia-Barrantes, Pedro M.;Camper, DeMarco;Chauder, Brian A.;Lee, Taekyu;Olejniczak, Edward T.;Fesik, Stephen W.
Myeloid cell leukemia-1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis. Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified two chemically distinct hit series that bind to different sites on Mcl-1. Members of the two fragment classes were merged together to produce lead compounds that bind to Mcl-1 with a dissociation constant of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2. Structures of merged compounds when complexed to Mcl-1 were obtained by X-ray crystallography and provide detailed information about the molecular recognition of small-molecule ligands binding Mcl-1. The compounds represent starting points for the discovery of clinically useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
--
作者:
Cohen NA;Stewart ML;Gavathiotis E;Tepper JL;Bruekner SR;Koss B;Opferman JT;Walensky LD
通讯作者:
Walensky LD
影响因子:
21.8
作者:
Murray, Christopher W.;Rees, David C.
通讯作者:
Rees, David C.
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
20.3
作者:
Derenne, S;Monia, B;Amiot, M
通讯作者:
Amiot, M